These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21677340)

  • 1. Course of a HBsAg positive liver transplantation in a hepatitis B and D virus coinfected recipient.
    Bahde R; Hölzen JP; Wolters HH; Schmidt HH; Bock CT; Lügering A; Spieker T; Senninger N; Brockmann JG
    Ann Hepatol; 2011; 10(3):355-60. PubMed ID: 21677340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
    Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis.
    Lerut JP; Donataccio M; Ciccarelli O; Roggen F; Jamart J; Laterre PF; Cornu C; Mazza D; Hanique G; Rahier J; Geubel AP; Otte JB
    J Hepatol; 1999 Apr; 30(4):706-14. PubMed ID: 10207814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.
    Samuel D; Zignego AL; Reynes M; Feray C; Arulnaden JL; David MF; Gigou M; Bismuth A; Mathieu D; Gentilini P
    Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft.
    Hwang S; Lee SG; Park KM; Kim KH; Ahn CS; Oh HB; Moon DB; Ha TY; Lim YS; Jung DH
    Liver Transpl; 2006 Jun; 12(6):993-7. PubMed ID: 16721765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft hepatitis delta virus reinfection after orthotopic liver transplantation in HDV cirrhosis.
    Reynès M; Zignego L; Samuel D; Fabiani B; Gugenheim J; Tricottet V; Brechot C; Bismuth H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2424-5. PubMed ID: 2652792
    [No Abstract]   [Full Text] [Related]  

  • 9. Course of hepatitis B and D virus infection in auxiliary liver grafts in hepatitis B-positive patients. A light-microscopic and immunohistochemical study.
    ten Kate FJ; Schalm SW; Willemse PJ; Blok AP; Heijtink RA; Terpstra OT
    J Hepatol; 1992 Mar; 14(2-3):168-75. PubMed ID: 1500681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of hepatitis delta virus reinfection and disease in liver transplantation.
    Ottobrelli A; Marzano A; Smedile A; Recchia S; Salizzoni M; Cornu C; Lamy ME; Otte JB; De Hemptinne B; Geubel A
    Gastroenterology; 1991 Dec; 101(6):1649-55. PubMed ID: 1955130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence of hepatitis D (delta) in liver transplants: histopathological aspects.
    David E; Rahier J; Pucci A; Camby P; Scevens M; Salizzoni M; Otte JB; Galmarini D; Marinucci G; Ottobrelli A
    Gastroenterology; 1993 Apr; 104(4):1122-8. PubMed ID: 8462801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus.
    Marsman WA; Wiesner RH; Batts KP; Poterucha JJ; Porayko MK; Niesters HG; Zondervan PE; Krom RA
    Hepatology; 1997 Feb; 25(2):434-8. PubMed ID: 9021960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
    Yu S; Yu J; Zhang W; Cheng L; Ye Y; Geng L; Yu Z; Yan S; Wu L; Wang W; Zheng S
    J Hepatol; 2014 Oct; 61(4):809-15. PubMed ID: 24824283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B Virus and Hepatitis D Virus Recurrence in Patients Undergoing Liver Transplantation for Hepatitis B Virus and Hepatitis B Virus Plus Hepatitis D Virus.
    Adil B; Fatih O; Volkan I; Bora B; Veysel E; Koray K; Cemalettin K; Burak I; Sezai Y
    Transplant Proc; 2016; 48(6):2119-23. PubMed ID: 27569956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver grafts from anti-hepatitis B core positive donors: a systematic review.
    Cholongitas E; Papatheodoridis GV; Burroughs AK
    J Hepatol; 2010 Feb; 52(2):272-9. PubMed ID: 20034693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha.
    Hopf U; Neuhaus P; Lobeck H; König V; Küther S; Bauditz J; Bechstein WO; Blumhardt G; Steffen R; Neuhaus R
    J Hepatol; 1991 Nov; 13(3):339-46. PubMed ID: 1808226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete hepatitis B virus prophylaxis withdrawal in hepatitis B surface antigen-positive liver transplant recipients after longterm minimal immunosuppression.
    Lenci I; Baiocchi L; Tariciotti L; Di Paolo D; Milana M; Santopaolo F; Manzia TM; Toti L; Svicher V; Tisone G; Perno CF; Angelico M
    Liver Transpl; 2016 Sep; 22(9):1205-13. PubMed ID: 27272189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
    Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.